abs61.txt	a	major	challenge	associated	with	biochemical	and	cellular	analysis	ofpseudokinases	is	lack	of	target-validated	small-molecule	compounds	whichto	probe	function		tribbles	2	(trib2)	cancer-associated	pseudokinase	adiverse	interactome	including	the	canonical	akt	signaling	module	there	issubstantial	evidence	that	human	trib2	promotes	survival	drug	resistance	insolid	tumors	blood	cancers	therefore	interest	as	therapeutictarget	unusual	domain	contains	unique	cysteine-richc-helix	interacts	conserved	peptide	motif	in	its	own	carboxyl-terminaltail	which	also	supports	interaction	e3	ubiquitin	ligases	we	foundthat	target	previously	described	protein	kinaseinhibitors	were	originally	designed	to	inhibit	kinasedomains	epidermal	growth	factor	receptor	tyrosine	kinase	family	members	usinga	thermal	shift	assay	discovered	trib2-binding	within	publishedkinase	inhibitor	set	(pkis)	used	repurposing	approach	classifycompounds	either	stabilized	or	destabilized	vitro	trib2destabilizing	agents	covalent	afatinib	led	rapid	trib2degradation	aml	cancer	cells	eliciting	tractable	effects	on	signalingand	our	data	reveal	new	leads	for	development	oftrib2-degrading	will	be	invaluable	unraveling	thecellular	mechanisms	trib2-based	study	highlights	smallmolecule-induced	down-regulation	through	off-targets	might	berelevant	other	inhibitors	serendipitously	pseudokinases
